ClinicalTrials.Veeva

Menu

Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

Samsung Medical Center logo

Samsung Medical Center

Status

Unknown

Conditions

Dry Eye

Treatments

Drug: Omega 3

Study type

Interventional

Funder types

Other

Identifiers

NCT04411615
2020-01-150

Details and patient eligibility

About

To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery

Enrollment

30 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Non complicated cataract surgery
  • Patients with dry eye symptom

Exclusion criteria

  • Using steroid eyedops,
  • Using antibiotics eyedrops
  • Surgery other than Cataract surgery
  • Contact lens wearer
  • Other systemic disease

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Omega
Experimental group
Description:
Omega-3 re-esterified triglyceride form
Treatment:
Drug: Omega 3

Trial contacts and locations

0

Loading...

Central trial contact

Tae-Young Chung

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems